CartilaGen Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 6

CartilaGen General Information


Developer of disease-modifying small-molecule drugs intended to prevent osteoarthritis after traumatic injury. The company's drugs offer joint lubrication and are nontoxic and inexpensive, enabling healthcare providers to cure their patients and improve their lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 2501 Crosspark Road
  • Unit E156M
  • Coralville, IA 52241
  • United States

CartilaGen Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CartilaGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 06-Jun-2020 Completed Generating Revenue
5. Early Stage VC Completed Startup
4. Grant 16-Sep-2019 0000 Completed Startup
3. Grant 02-May-2016 000 Completed Startup
2. Grant 30-Apr-2016 $5K Completed Startup
1. Grant 10-Apr-2016 $2K Completed Startup
To view CartilaGen’s complete valuation and funding history, request access »

CartilaGen Executive Team (2)

Name Title Board Seat Contact Info
Frank Yu Ph.D Co-Founder & Co-Chief Executive Officer
Jaison Marks Co-Founder & Co-Chief Executive Officer
To view CartilaGen’s complete executive team members history, request access »

CartilaGen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CartilaGen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UIVentures Accelerator/Incubator Minority 000 0000 000000 0
Pappajohn Entrepreneurial Center Accelerator/Incubator 000 0000 000000 0
Columbia University Graduate School of Business Other 000 0000 000000 0
The Chinese University of Hong Kong University 000 0000 000000 0
Harvard University Endowment Limited Partner 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »